Aurobindo Pharma receives USFDA approval for Cephalexin Tablets

Aurobindo Pharma receives USFDA approval for Cephalexin Tablets


Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Cephalexin Tablets USP, 250 mg and 500 mg, which is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Keflet Tablets, 250 mg and 500 mg, of Eli Lilly and Company.

Aurobindo Pharma was granted Competitive Generic Therapy (CGT) designation for Cephalexin Tablets USP, 250 mg and 500 mg, and is eligible for 180 days of shared generic drug exclusivity. The product is expected to be launched in Q3FY25.

Click here to connect with us on WhatsApp

Cephalexin Tablets USP, 250 mg and 500 mg are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms.

 

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 01 2024 | 4:30 PM IST



Source link

Aurobindo Pharma receives USFDA approval for Cephalexin Tablets

Diffusion Engineers IPO ends with nearly 114x subscription


The offer received bids for 75.54 crore shares as against 65.98 lakh shares on offer.

The initial public offer (IPO) of Diffusion Engineers received 75,54,83,608 bids for shares as against 65,98,500 shares on offer. The issue was subscribed 114.49 times.

The Qualified Institutional Buyers (QIBs) category was subscribed 95.74 times. The Non Institutional Investors (NIIs) category was subscribed 207.60 times. The Retail Individual Investors (RIIs) category was subscribed 85.61 times.

Click here to connect with us on WhatsApp

The issue opened for bidding on 26 September 2024 and it closed on 30 September 2024. The price band of the IPO was fixed between Rs 159 to 168 per share.

 

The IPO comprises fresh issue of equity shares of 9405000 equity share of Rs 10 face value.

Of the net proceeds from the fresh issue, about Rs 71.38 crore will be used for funding capital expenditure requirements towards expansion of its existing manufacturing facility Unit IV at Khapri (Uma) in Nagpur, Rs 30.385 crore towards setting up of a new manufacturing facility located at Hingna in Sonegaon District of Maharashtra, Rs 22 crore towards funding working capital requirements of the company and balance for general corporate purposes.

Ahead of the IPO, Diffusion Engineers on Thursday, 5 September 2024, raised Rs 47.14 crore from anchor investors. The board allotted 28.06 lakh shares at Rs 168 each to 5 anchor investors.

Diffusion Engineers, promoted by Prashant Garg, manufactures welding consumables, wear plates and wear parts and heavy engineering machinery for core industries. It provides specialized repairs and reconditioning services for heavy machinery and equipment and trades anti-wear powders and welding and cutting machinery.

The company provides super conditioning process at its manufacturing facilities, a surface treatment solution for machine components that enhances wear resistance, eliminates stress and improves their repairability ultimately extending their lifespan and reducing production costs.

The firm reported a consolidated net profit of Rs 30.80 crore and sales of Rs 278.14 crore for the twelve months ended on 31 March 2024.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 01 2024 | 4:27 PM IST



Source link

Aurobindo Pharma receives USFDA approval for Cephalexin Tablets

GE Power India wins contract for 100 MW Super Trishuli HPP


GE Power India has received a contract from Blue Energy for Design, Engineering, Procurement, Supply of Turbine, Governing, Generator, Control and Protection System up to project site, erection,
testing and commissioning of GE Vernova supplied equipment for 100MW Super Trishuli HPP. The value of the contract is Rs 240.4 crore and NPR (Nepalese Rupee) 340 million.

Powered by Capital Market – Live News

Click here to connect with us on WhatsApp

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 01 2024 | 4:26 PM IST



Source link

Aurobindo Pharma receives USFDA approval for Cephalexin Tablets

Birla Estates garners revenue of Rs 600 cr in Birla Trimaya Phase II project


Birla Estates, a wholly owned subsidiary of Aditya Birla Real Estate (formerly Century Textiles and Industries) today announced that Birla Trimaya Phase II – The Park, has sold almost 95% of its inventory within 24 hours of its launch achieving an approximate booking value of about Rs 600 crore. This sales success follows the record-breaking performance of Phase I of Birla Trimaya, which secured approximately Rs 500 crore in bookings within just 36 hours of its launch. Overall, the cumulative booking value achieved till date is approx. Rs 1,100 crore and the project is anticipated to generate a revenue potential of around Rs 3,000 crore across the entire 52 acre development.

 

Set in the prime location of Shettigere Road, Devanahalli, Bengaluru North, the project is spread across an expansive 52 acres of land parcel. Building on the success of Phase I, Birla Trimaya Phase II – The Park, presents a thoughtfully curated collection of apartments, row houses and duplex homes, catering to the diverse needs of discerning homebuyers with customised home configurations. Its strategic location, coupled with the exceptional design, represents a significant opportunity for homebuyers looking to invest in North Bengaluru’s fast-growing real estate market

Click here to connect with us on WhatsApp

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 01 2024 | 4:18 PM IST



Source link

Aurobindo Pharma receives USFDA approval for Cephalexin Tablets

Quick Wrap: Nifty Media Index records a surge of 1.60%


Nifty Media index ended up 1.60% at 2172.75 today. The index has added 3.00% over last one month. Among the constituents, Saregama India Ltd rose 6.77%, Dish TV India Ltd gained 4.84% and Sun TV Network Ltd jumped 1.99%. The Nifty Media index has decreased 4.00% over last one year compared to the 31.36% spike in benchmark Nifty 50 index. In other indices, Nifty IT index increased 1.17% and Nifty Energy index is down 0.75% on the day. In broad markets, the Nifty 50 is down 0.05% to close at 25796.9 while the SENSEX has slid 0.04% to close at 84266.29 today.

Powered by Capital Market – Live News

 

Click here to connect with us on WhatsApp

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 01 2024 | 4:00 PM IST



Source link

Aurobindo Pharma receives USFDA approval for Cephalexin Tablets

Mphasis elects Jan Kathleen Hier as Chairperson of Board


Mphasis announced the election of Jan Kathleen Hier, the Company’s
Independent Director since December 2015, as the Chairperson of the Board, effective 1 October 2024. Hier succeeds Davinder Singh Brar, who retires effective 30 September 2024, consequent to successful
completion of term, as an Independent Director, approved by the shareholders.

Hier previously served as a partner at a start-up and as Executive Vice President at Charles Schwab, where she led centralized support services, including Schwab Technology Services, Operational Services, Corporate
Project Management, Operational Risk Management, and Offshore Services. During her tenure at Schwab, she also held several senior leadership positions, including Chief Information Officer, Executive Vice President of Human Resources, and Head of Electronic Brokerage Technology.

 

Powered by Capital Market – Live News

Click here to connect with us on WhatsApp

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 01 2024 | 3:46 PM IST



Source link

YouTube
Instagram
WhatsApp